HAE
Haemonetics Corporation · Healthcare · Medical - Devices
Señales de momentum (gestores comparables):
amplitud de titulares +6.2% ·
flujo de acciones -2.1% ·
nuevas posiciones netas +5.9%
· fórmula
Fragmentación de la titularidad: más titulares, participación agregada más pequeña
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q2 2025
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 104 | -6 | 39.44M | $2.63B | +3 | −11 |
| Q1 2026 | 115 | +1 | 38.93M | $1.98B | +9 | −9 |
| Q4 2025 | 115 | -1 | 49.79M | $3.32B | +2 | −2 |
| Q3 2025 | 19 | 0 | 21.92M | $1.07B | +1 | −2 |
| Q2 2025 | 17 | +1 | 20.74M | $1.55B | +1 | n/a |
| Q1 2025 | 13 | -1 | 9.03M | $573.92M | +1 | −2 |
| Q4 2024 | 14 | 0 | 9.30M | $726.05M | +1 | −1 |
| Q3 2024 | 13 | -3 | 7.86M | $631.67M | n/a | −3 |
| Q2 2024 | 16 | n/a | 7.65M | $633.10M | n/a | n/a |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (pasivo) | 6.36M | n/a | $474.88M | 0.0% | n/c | 1 | SEC ↗ ×18 |
| 2 | The Vanguard Group ✦ (pasivo) | 4.95M | n/a | $369.57M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 3 | Wellington Management ✦ | 2.15M | -18.2% | $160.13M | 0.0% | ▼ Trim | 5 | SEC ↗ ×8 |
| 4 | State Street Global Advisors ✦ (pasivo) | 1.88M | -1.8% | $140.56M | 0.0% | ▼ Trim | 3 | SEC ↗ ×3 |
| 5 | Geode Capital Management ✦ (pasivo) | 1.24M | +1.9% | $92.87M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 6 | Fidelity (FMR) ✦ | 835.85K | n/a | $62.36M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 7 | Fisher Asset Management ✦ | 689.14K | -6.2% | $51.42M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 8 | Marshall Wace ✦ | 515.97K | -20.4% | $38.50M | 0.0% | ▼ Trim | 5 | SEC ↗ ×3 |
| 9 | Norges Bank ✦ (pasivo) | 493.52K | -3.6% | $36.82M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 10 | AQR Capital Management ✦ | 450.25K | +157.9% | $33.39M | 0.0% | ▲ Add | 5 | SEC ↗ ×4 |
| 11 | Point72 Asset Management ✦ | 438.32K | +4.1% | $32.70M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 12 | T. Rowe Price ✦ | 361.44K | +1.2% | $26.97M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 13 | Citadel Advisors ✦ | 252.63K | -29.5% | $18.85M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 14 | Bridgewater Associates ✦ | 46.28K | +115.1% | $3.45M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 15 | Millennium Management ✦ | 37.59K | +2.1% | $2.80M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 16 | Gotham Asset Management ✦ | 22.84K | +388.1% | $1.70M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 17 | Two Sigma Investments ✦ | 7.12K | Nuevo | $531,372 | 0.0% | New | 1 | SEC ↗ ×2 |
"Their weight" = la participación de la posición en el valor de renta variable 13F reportado por ese manager: la medida de convicción. ✦ = manager curado.
Nuevos compradores
| Two Sigma Investments | $531,372 | 0.0% |
Posición cerrada
| Sin salidas rastreadas este trimestre. |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 321 tenedores, 47.04M acciones, $2.56B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué más suelen tener los titulares rastreados de este valor: recuentos de titularidad compartida, no relaciones fundamentales.